{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T11:10:26Z","timestamp":1768475426965,"version":"3.49.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","lrjournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.leukres.2017.09.007","type":"journal-article","created":{"date-parts":[[2017,9,13]],"date-time":"2017-09-13T04:46:43Z","timestamp":1505278003000},"page":"77-83","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Establishment of cell line with NK\/NKT phenotype from myeloid NK cell acute leukemia"],"prefix":"10.1016","volume":"61","author":[{"given":"A.","family":"Darji","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Desai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Modi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Khamar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Rajkumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2017.09.007_bib0005","series-title":"Acute Myeloid Leukemia \u2014 Cancer Stat Facts","year":"2017"},{"key":"10.1016\/j.leukres.2017.09.007_bib0010","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/leu.2014.216","article-title":"Management of older or unfit patients with acute myeloid leukemia","volume":"29","author":"Walter","year":"2015","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2017.09.007_bib0015","series-title":"Human Leukemia and Lymphoma Cell Lines as Models and Resources","first-page":"339","author":"Macleod","year":"2008"},{"key":"10.1016\/j.leukres.2017.09.007_bib0020","series-title":"History of Leukemia-Lymphoma Cell Lines","first-page":"75","author":"Drexler","year":"2010"},{"key":"10.1016\/j.leukres.2017.09.007_bib0025","first-page":"2391","volume":"127","author":"Arber","year":"2016"},{"key":"10.1016\/j.leukres.2017.09.007_bib0030","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S0145-2126(00)00070-9","article-title":"Continuous hematopoietic cell lines as model systems for leukemia-lymphoma research","volume":"24","author":"Drexler","year":"2000","journal-title":"Leuk. Res."},{"key":"10.1016\/j.leukres.2017.09.007_bib0035","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1080\/07853890310012094","article-title":"Leukemia-lymphoma cell lines as model systems for hematopoietic research","volume":"35","author":"Drexler","year":"2003","journal-title":"Ann. Med."},{"key":"10.1016\/j.leukres.2017.09.007_bib0040","doi-asserted-by":"crossref","first-page":"52","DOI":"10.2174\/1389201016666150826115626","article-title":"Global cell proteome profiling, phospho-signaling and quantitative proteomics for identification of new biomarkers in acute myeloid leukemia patients","volume":"17","author":"Aaseb\u00f8","year":"2016","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.leukres.2017.09.007_bib0045","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1182\/blood.V84.1.244.244","article-title":"HLA-DR-, CD33+, CD56+, CD16- myeloid\/natural killer cell acute leukemia: a previously unrecognized form of acute leukemia potentially misdiagnosed as French-American-British acute myeloid leukemia-M3","volume":"84","author":"Scott","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2017.09.007_bib0050","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1182\/blood.V90.6.2417","article-title":"{CD7+} and {CD56+} myeloid\/natural killer cell precursor acute leukemia: a distinct hematolymphoid disease entity","volume":"90","author":"Suzuki","year":"1997","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.leukres.2017.09.007_bib0055","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1093\/ajcp\/104.2.212","article-title":"Natural killer cell acute leukemia with myeloid antigen expression. A previously undescribed form of acute leukemia","volume":"104","author":"Dunphy","year":"1995","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.leukres.2017.09.007_bib0060","first-page":"77","article-title":"Isolation of mononuclear cells by one centrifugation, and of granulocytes by combininb centrifugation and sedimentation at 1g","volume":"21","author":"B\u00f6yum","year":"1968","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"10.1016\/j.leukres.2017.09.007_bib0065","first-page":"71","article-title":"Separation of lymphocytes, lymphocyte subgroups and monocytes: a review","volume":"10","author":"Boyum","year":"1977","journal-title":"Lymphology"},{"key":"10.1016\/j.leukres.2017.09.007_bib0070","doi-asserted-by":"crossref","first-page":"5.1. 1","DOI":"10.1002\/0471142956.cy0501s73","article-title":"Collection, storage, and preparation of human blood cells","volume":"2015","author":"Dagur","year":"2015","journal-title":"Curr. Protoc. Cytom."},{"key":"10.1016\/j.leukres.2017.09.007_bib0075","series-title":"Further Characterization of Complex Chromosomal Rearrangements in Myeloid Malignancies: Spectral Karyotyping Adds Precision in Defining Abnormalities Associated with Poor Prognosis","first-page":"1133","author":"Grove","year":"2001"},{"key":"10.1016\/j.leukres.2017.09.007_bib0080","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/gcc.1212","article-title":"Identification of cytogenetic subclasses and recurring chromosomal aberrations in AML and MDS with complex karyotypes using M-FISH","volume":"33","author":"Ricketts","year":"2002","journal-title":"Genes Chromosome Cancer"},{"key":"10.1016\/j.leukres.2017.09.007_bib0085","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0145-2126(98)00050-2","article-title":"Establishment and characterization of human B cell precursor-leukemia cell lines","volume":"22","author":"Matsuo","year":"1998","journal-title":"Leuk. Res."},{"key":"10.1016\/j.leukres.2017.09.007_bib0090","first-page":"269","article-title":"Establishment of undifferentiated leukemia cell line (Kasumi-3) with t(3;7)(q27;q22) and activation of the EVI1 gene Hiroya Asou, Kasumi Suzukawa, Kenkichi Kita, Kazunori Nakase, Huruo Udea, Kazuhiro Morishita and Nanao Kamada, Japan","volume":"86","author":"Hiroya Asou","year":"1996","journal-title":"J. Cancer Res."},{"key":"10.1016\/j.leukres.2017.09.007_bib0095","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/gcc.10161","article-title":"Establishment of the acute myeloid leukemia cell line kasumi-6 from a patient with a dominant-negative mutation in the DNA-binding region of the C\/EBP alpha gene","volume":"36","author":"Asou","year":"2003","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.leukres.2017.09.007_bib0100","series-title":"Hematologic Diseases Characterization of Complex Chromosomal Rearrangements in Acute Myeloid Leukemia: FISH and Multicolor FISH Add Precision in Defining Abnormalities Associated with Poor Prognosis","first-page":"1","author":"Patel","year":"2016"},{"key":"10.1016\/j.leukres.2017.09.007_bib0105","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1177\/1947601911408076","article-title":"Genetic abnormalities and challenges in the treatment of acute myeloid leukemia","volume":"2","author":"Kumar","year":"2011","journal-title":"Genes Cancer"},{"key":"10.1016\/j.leukres.2017.09.007_bib0110","series-title":"Immunophenotypic pattern of myeloid populations by flow cytometry analysis","author":"Gorczyca","year":"2011"},{"key":"10.1016\/j.leukres.2017.09.007_bib0115","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/cyto.b.21087","article-title":"Combined flow cytometric assessment of CD45, HLA-DR, CD34, and CD117 expression is a useful approach for reliable quantification of blast cells in myelodysplastic syndromes","volume":"84\u2009B","author":"Sandes","year":"2013","journal-title":"Cytom. Part B Clin. Cytom."},{"key":"10.1016\/j.leukres.2017.09.007_bib0120","first-page":"24","article-title":"Standard immunophenotyping of leukemia cells in acute myeloid leukemia (AML)","volume":"33","author":"Wozniak","year":"2008","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.leukres.2017.09.007_bib0125","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/cncr.23219","article-title":"Prognostic value of immunophenotyping in elderly patients with acute myeloid leukemia: a single-institution experience","volume":"112","author":"Plesa","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.leukres.2017.09.007_bib0130","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1182\/blood.V97.10.3146","article-title":"Human natural killer cells: a unique innate immunoregulatory role for the CD56 bright subset","volume":"97","author":"Cooper","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2017.09.007_bib0135","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1600-065X.2006.00454.x","article-title":"Functional subsets of mouse natural killer cells","volume":"214","author":"Hayakawa","year":"2006","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.leukres.2017.09.007_bib0140","first-page":"461","article-title":"Human natural killer cells","volume":"112","author":"Caligiuri","year":"2008","journal-title":"Bone"},{"key":"10.1016\/j.leukres.2017.09.007_bib0145","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/j.1365-2567.2008.03027.x","article-title":"CD56bright natural killer (NK) cells: an important NK cell subset","volume":"126","author":"Poli","year":"2009","journal-title":"Immunology"},{"key":"10.1016\/j.leukres.2017.09.007_bib0150","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.4049\/jimmunol.1502570","article-title":"Human CD56 bright NK cells: an update","volume":"196","author":"Michel","year":"2016","journal-title":"J. Immunol."},{"key":"10.1016\/j.leukres.2017.09.007_bib0155","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1002\/1521-4141(2001010)31:10<3121::AID-IMMU3121>3.0.CO;2-4","article-title":"CD56bright cells differ in their KIR repertoire and cytotoxic features from CD56dim NK cells","volume":"31","author":"Jacobs","year":"2001","journal-title":"Eur. J. Immunol."},{"issue":"19","key":"10.1016\/j.leukres.2017.09.007_bib0160","doi-asserted-by":"crossref","first-page":"3689","DOI":"10.1182\/blood-2010-09-303057","article-title":"dim human NK cells Dissecting","volume":"116","author":"Moretta","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2017.09.007_bib0165","first-page":"577","article-title":"Evaluation of CD56dim and CD56bright natural killer cells in peripheral blood of women with IVF failures","volume":"13","author":"Mardanian","year":"2015","journal-title":"Iran. J. Reprod. Med."},{"key":"10.1016\/j.leukres.2017.09.007_bib0170","doi-asserted-by":"crossref","first-page":"473","DOI":"10.3816\/CLML.2010.n.082","article-title":"A phase II trial of gemcitabine and mitoxantrone for patients with acute myeloid leukemia in first relapse","volume":"10","author":"Advani","year":"2010","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"10.1016\/j.leukres.2017.09.007_bib0175","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s00282-999-0195-3","article-title":"Therapy related acute myeloid leukemia after exposure to 5-Fluorouracil: a case report","volume":"41","author":"Turker","year":"1999","journal-title":"Hematol. Cell Ther."},{"key":"10.1016\/j.leukres.2017.09.007_bib0180","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3904\/kjim.2012.27.1.115","article-title":"A case of therapy-related acute myeloid leukemia following 5-fluorouracil chemotherapy","volume":"27","author":"Park","year":"2012","journal-title":"Korean J. Intern. Med."},{"key":"10.1016\/j.leukres.2017.09.007_bib0185","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1756-8722-2-21","article-title":"Temozolomide and cisplatin in relapsed\/refractory acute leukemia","volume":"2","author":"Seiter","year":"2009","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.leukres.2017.09.007_bib0190","first-page":"8581421","article-title":"Complete remission of acute myeloid leukemia following cisplatin based concurrent therapy with radiation for squamous cell laryngeal cancer","volume":"2016","author":"Mody","year":"2016","journal-title":"Case Rep. Hematol."},{"key":"10.1016\/j.leukres.2017.09.007_bib0195","doi-asserted-by":"crossref","first-page":"5244","DOI":"10.1016\/j.biomaterials.2013.03.006","article-title":"Aptamer-conjugated and doxorubicin-loaded unimolecular micelles for targeted therapy of prostate cancer","volume":"34","author":"Xu","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.leukres.2017.09.007_bib0200","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1586\/14737159.4.5.705","article-title":"Assessment of drug resistance in acute myeloid leukemia","volume":"4","author":"Funato","year":"2004","journal-title":"Exp. Rev. Mol. Diagn."},{"key":"10.1016\/j.leukres.2017.09.007_bib0205","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1002\/cncr.28098","article-title":"Multidrug resistance in relapsed acute myeloid leukemia: evidence of biological heterogeneity","volume":"119","author":"Patel","year":"2013","journal-title":"Cancer"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212617305155?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212617305155?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,17]],"date-time":"2020-10-17T15:02:31Z","timestamp":1602946951000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212617305155"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":41,"alternative-id":["S0145212617305155"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2017.09.007","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Establishment of cell line with NK\/NKT phenotype from myeloid NK cell acute leukemia","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2017.09.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}